Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers.
- Published In:
- Current medicinal chemistry, 13(20), 2345-52 (2006)
- Authors:
- Oka, Y, Tsuboi, A, Kawakami, M, Elisseeva, O A, Nakajima, H, Udaka, K, Kawase, I, Oji, Y, Sugiyama, H
- Database ID:
- RPEP-01175
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01175APA
Oka, Y; Tsuboi, A; Kawakami, M; Elisseeva, O A; Nakajima, H; Udaka, K; Kawase, I; Oji, Y; Sugiyama, H. (2006). Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers.. Current medicinal chemistry, 13(20), 2345-52.
MLA
Oka, Y, et al. "Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers.." Current medicinal chemistry, 2006.
RethinkPeptides
RethinkPeptides Research Database. "Development of WT1 peptide cancer vaccine against hematopoie..." RPEP-01175. Retrieved from https://rethinkpeptides.com/research/oka-2006-development-of-wt1-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.